MedaSystems
Healthcare Software · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3475 Edison Way Ste R, Menlo Park, Calif...Phone Number
(408) 384-9392Website
www.medasystems.comRevenue
$5.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About MedaSystems
MedaSystems is the leading developer of software for managing requests for experimental therapies, supporting Expanded Access, Post-Trial Access, and Investigator-Initiated Studies. Its secure, GxP-compliant application serves as a centralized environment that connects physicians and pharmaceutical companies, facilitating global patient access to investigational therapies. By enabling seamless tracking, inquiry management, and data collection, MedaSystems transforms communication between clinicians and life sciences teams, significantly reducing administrative burden and improving collaboration.Explore more
MedaSystems Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MedaSystems your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if MedaSystems had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at MedaSystems
Earning: See what the market has to say on MedaSystems recently announced quarterly report
Check if MedaSystems has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when MedaSystems launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once MedaSystems has new funding data
Check out if MedaSystems is spiking on competitors!
MedaSystems, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at MedaSystems
Find more new buyers
Compare Similar Companies to MedaSystems
Compare insights from companies similar to MedaSystems, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
MedaSystems is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
MedaSystems is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about MedaSystems.
MedaSystems financials insights
Gather financial insights about MedaSystems, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Other Financing Round
$1.5M
MedaSystems Tech Stack
A closer look at the technologies used by MedaSystems
Most Recent Scoops
Person-Based
Funding
Funding
New Hire
Executive Move
Executive Moves, New Hire, Board of Directors
Open Position
Funding
MedaSystems News & Media
MedaSystems Secures Additional Seed Financing to Advance Its AI-Driven Workflow Platform for Expanded Access and Investigator-Initiated Studies
MENLO PARK, Calif.--(BUSINESS WIRE)--MedaSystems, the leading SaaS platform for Expanded Access (EA) and Investigator-Initiated Studies (IIS), today announced additional funding from existing investors, Debiopharm Innovation Fund, Nina Capital, and Young Sohn, a co-founder of Veeva Systems. This investment underscores confidence in MedaSystems’ ability to modernize pre-approval access pathways through its AI-driven workflow platform. By streamlining Expanded Access and IIS workflows, MedaSystemMedaSystems Appoints Healthcare Technology Leader Brian Irwin to Spearhead Next Stage of Growth
MENLO PARK, Calif.--(BUSINESS WIRE)--MedaSystems, the leading SaaS platform for Expanded Access and Investigator Initiated Trials, is pleased to announce the recent appointment of Brian Irwin as Chief Executive Officer and Board Member. With over 25 years of strategic leadership in Life Science data analytics, SaaS technology, and healthcare investing, Brian joins MedaSystems at a pivotal time, bringing an impressive track record in scaling growth within these sectors. “I’m thrilled to join MedMedaSystems Receives Additional Funding
MedaSystems, a Menlo Park, CA-based provider of software for access to pre-approval medicine, received additional funding from Debiopharm Innovation Fund. The amount of the deal was not disclosed. Led by Fiona Smythe, MedaSystems is a developer of software that streamlines the handling of requests for experimental therapies from healthcare providers, supporting both Expanded Access and […] The post MedaSystems Receives Additional Funding appeared first on FinSMEs.MedaSystems Secures Additional Funding from Debiopharm Innovation Fund to Accelerate Global Access to Pre-approval Treatment
MENLO PARK, Calif. & LAUSANNE, Switzerland--(BUSINESS WIRE)--MedaSystems, a pioneer in software to provide access to pre-approval medicine, is pleased to announce additional funding from Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, motivated by their vision of patient centric, data-enabled clinical research and enabling patients to access novel treatments sooner. The investment adds to a growing list of prominent digital health investor
Read more news
Top Healthcare Software Companies
See more top companies
Frequently Asked Questions Regarding MedaSystems
Sign Up For FreeTo access detailed company insights
MedaSystems is the leading developer of software for managing requests for experimental therapies, supporting Expanded Access, Post-Trial Access, and Investigator-Initiated Studies. Its secure, GxP-compliant application serves as a centralized environment that connects physicians and pharmaceutical companies, facilitating global patient access to i... Read More
